In the present experiments, exposure to selective BRAF inhibitors activated AMPK in conjunction with clearly increased autophagic activity, and subsequent inhibition of autophagy sensitized BRAFV600E CRC cells to selective BRAF inhibitors. This evidence concerns the gene BRAF and colorectal carcinoma.